title: Phase I study of oral bioflavonoids in cadaveric renal transplant recipients: effects on delayed graft function and calcineurin inhibitor toxicities.
authors.affiliation: Department of Urology, Cleveland Clinic Florida, Weston, Florida, USA. dshoskes@mac.com
authors.forename: D A
authors.initials: DA
authors.lastname: Shoskes
authors.forename: M
authors.initials: M
authors.lastname: Thomas
authors.forename: R
authors.initials: R
authors.lastname: Pobgee
authors.forename: B
authors.initials: B
authors.lastname: Fromkin
authors.forename: J B
authors.initials: JB
authors.lastname: Copley
mesh_terms: D000284:Administration, Oral; D065095:Calcineurin Inhibitors; D003404:Creatinine / Q000097:blood; D005419:Flavonoids / Q000008:administration & dosage / Q000009:adverse effects*; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D016030:Kidney Transplantation / Q000473:pathology / Q000502:physiology*; D013997:Time Factors; D014019:Tissue Donors
chemical_list: D065095:Calcineurin Inhibitors; D005419:Flavonoids; D003404:Creatinine